Atlas Trials

Study of Adjuvant ONO-4538 With Resected Gastric Cancer

Clinical trial NCT03006705 · COMPLETED

Trial details

NCT number
NCT03006705
Sponsor
Ono Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Gastric Cancer
Start date
2017-01-31
Primary completion
2022-08-17
Enrollment
800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.